查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1298837

按藥物類別、適應症（胃食道逆流病或胃灼熱、便秘、腹瀉、暈動症及其他）、終端用戶和地區分類的胃腸道OTC藥物市場2023-2028年

Gastrointestinal OTC Drugs Market by Drug Class, Indication (Gastroesophageal Reflux Disease or Heartburn, Constipation, Diarrhea, Motion Sickness, and Others), End User, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2022年，全球胃腸道非處方藥市場規模達到400億美元。展望未來，IMARC Group預計，到2028年，市場規模將達到524億美元，在2023-2028年期間表現出4.90%的成長率（CAGR）。胃腸道疾病的發病率不斷上升，大眾對消化系統健康的認知不斷提高，以及最近先進配方的開發代表了推動市場的一些關鍵因素。

胃腸道非處方藥（OTC）是指緩解胃腸道症狀和促進整體消化系統健康的非處方藥。它包括瀉藥、抗酸劑、H2阻斷劑、質子泵抑製劑（PPI）、止吐劑、腸道消炎劑和止瀉藥。胃腸道非處方藥被廣泛用於治療消化不良、便秘、胃灼熱、腹瀉、暈車、胃酸逆流、噁心、大腸急躁症（IBS）和腹痛。它是一種具有成本效益的、方便的、容易獲得的產品，能夠提供即時的緩解，提高病人的舒適度，並允許自我管理。胃腸道OTC藥物還有助於改善腸道健康，恢復有益細菌，預防未來的併發症，並最大限度地減少各種症狀的嚴重性，如疼痛、腹脹、腹部不適和嘔吐。

胃腸道非處方藥市場趨勢：

由於久坐的生活方式和不健康的飲食習慣，胃腸道疾病的發病率不斷上升，這是推動市場成長的關鍵因素之一。胃腸道非處方藥被廣泛用於治療感染、消化不良、急性腹瀉、胃灼熱、胃食道逆流病（GERD）、便秘、腹脹和晨吐。此外，由於大眾對消化健康的認知不斷提高，越來越多的產品應用於改善消化，促進腸道健康，並確保營養物質的適當分解和吸收，這為市場成長提供了動力。與此相呼應，新興的自我保健和消費者授權管理健康和預防未來健康併發症的趨勢正在成為另一個成長誘導因素。此外，最近開發的先進配方，如發泡錠、液體、懸浮液、薄膜條和咀嚼產品，提高了藥物的有效性，增加了吸收，減少了用藥頻率，正在對市場成長產生積極影響。除此之外，方便和便於旅行的包裝，如吸塑包裝、可重複密封的小袋和單劑量包裝的推出，正在推動市場成長。除此之外，消費者對非侵入性治療的偏好上升，促進了對管理常見消化問題和提供即時救濟的產品需求。此外，一些製造商通過電視（TV）廣告、社交媒體、影響者行銷和名人代言進行的積極宣傳和品牌推廣活動正在加強市場成長。其他因素，包括老年人口的增加，消費者支出能力的提高，以及電子商務平台上產品的容易獲得，預計將推動市場的成長。

本報告中回答的關鍵問題：

  • 迄今為止，全球胃腸道非處方藥市場表現如何，未來幾年將如何表現？
  • 全球胃腸道非處方藥市場的驅動因素、限制因素和機會是什麼？
  • 每個驅動因素、限制因素和機會對全球胃腸道OTC藥物市場的影響是什麼？
  • 主要的區域市場是什麼？
  • 哪些國家代表了最具吸引力的胃腸道非處方藥市場？
  • 基於藥物類別的市場細分是什麼？
  • 胃腸道非處方藥市場中最有吸引力的藥物類別是什麼？
  • 基於適應症的市場詳細情形是怎樣的？
  • 胃腸道OTC藥物市場中最有吸引力的適應症是什麼？
  • 基於終端用戶的市場細分是什麼？
  • 在胃腸道非處方藥市場中，哪一個是最有吸引力的終端用戶？
  • 全球胃腸道OTC藥物市場的競爭結構是什麼？
  • 誰是全球胃腸道OTC藥物市場的主要參與者/公司？

目錄

第一章：前言

第二章：範圍和方法

  • 研究的目標
  • 利益相關者
  • 數據來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章：執行摘要

第四章：簡介

  • 概述
  • 主要行業趨勢

第五章：全球胃腸道非處方藥市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章：按藥物類別分類的市場

  • 瀉藥
    • 市場趨勢
    • 市場預測
  • 胃腸道癌症治療藥物
    • 市場趨勢
    • 市場預測
  • 胃酸減少劑
    • 市場趨勢
    • 市場預測
  • 止瀉藥
    • 市場趨勢
    • 市場預測
  • 質子泵抑製劑
    • 市場趨勢
    • 市場預測
  • H2抑製劑
    • 市場趨勢
    • 市場預測
  • 胃酸中和劑
    • 市場趨勢
    • 市場預測
  • 腸道抗炎劑
    • 市場趨勢
    • 市場預測
  • 抗化妝品
    • 市場趨勢
    • 市場預測

第7章：按適應症分類的市場

  • 胃食道逆流病（GERD）或胃灼熱病
    • 市場趨勢
    • 市場預測
  • 便秘
    • 市場趨勢
    • 市場預測
  • 腹瀉
    • 市場趨勢
    • 市場預測
  • 暈動症
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第8章：按終端用戶分類的市場

  • 醫院
    • 市場趨勢
    • 市場預測
  • 診所
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第九章：按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳大利亞
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第十章：驅動因素、限制因素和機會

  • 概述
  • 驅動因素
  • 限制因素
  • 機會

第十一章：價值鏈分析

第十二章：波特五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第十三章：價格分析

第十四章：競爭格局

  • 市場結構
  • 主要參與者
  • 主要參與者的簡介
    • Boehringer Ingelheim GmbH
    • Johnson & Johnson
    • Prestige Consumer Healthcare Inc.
    • Purdue Pharma LP
    • Sanofi
    • Zydus Lifesciences Limited

請注意，這只代表部分公司的名單，完整的名單已在報告中提供。

Product Code: SR112023A7781

The global gastrointestinal OTC drugs market size reached US$ 40 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 52.4 Billion by 2028, exhibiting a growth rate (CAGR) of 4.90% during 2023-2028. The rising prevalence of gastrointestinal disorders, increasing awareness among the masses regarding digestive health, and the recent development of advanced formulations represent some of the key factors driving the market.

Gastrointestinal over-the-counter (OTC) drugs refer to non-prescription medications that alleviate gastrointestinal symptoms and promote overall digestive wellness. It includes laxatives, antacids, H2 blockers, proton pump inhibitors (PPIs), anti-emetics, bowel anti-inflammatory, and anti-diarrheal medications. Gastrointestinal OTC drugs are widely used to treat indigestion, constipation, heartburn, diarrhea, motion sickness, acid reflux, nausea, irritable bowel syndrome (IBS), and abdominal pain. It is a cost-effective, convenient, and easily accessible product that provides immediate relief, enhances patient comfort, and allows self-management. Gastrointestinal OTC drugs also aid in improving gut health, restoring beneficial bacteria, preventing future complications, and minimizing the severity of various symptoms, such as pain, bloating, abdominal discomfort, and vomiting.

Gastrointestinal OTC Drugs Market Trends:

The rising prevalence of gastrointestinal disorders due to sedentary lifestyles and unhealthy eating habits is one of the key factors providing a thrust to the market growth. Gastrointestinal OTC drugs are widely used to treat infections, dyspepsia, acute diarrhea, heartburn, gastroesophageal reflux disease (GERD), constipation, bloating, and morning sickness. Furthermore, the increasing product applications to improve digestion, promote gut health, and ensure proper breakdown and absorption of nutrients, owing to the growing awareness among the masses regarding digestive health, is providing an impetus to the market growth. In line with this, the emerging trends of self-care and consumer empowerment to manage well-being and prevent future health complications are acting as another growth-inducing factor. Additionally, the recent development of advanced formulations, such as effervescent tablets, liquids, suspensions, film strips, and chewable products, which enhances the effectiveness of the drugs, increases absorption, and reduces the frequency of dosing, is positively influencing the market growth. Besides this, the introduction of convenient and travel-friendly packaging, such as blister packs, resealable pouches, and single-dose packets, is propelling the market growth. Apart from this, the rising consumer preference for non-invasive treatments is facilitating product demand to manage common digestive issues and provide immediate relief. Moreover, aggressive promotional and branding campaigns by several manufacturers through television (TV) commercials, social media, influencer marketing, and celebrity endorsement is strengthening the market growth. Other factors, including the rising geriatric populations, increasing expenditure capacities of consumers, and easy availability of products across e-commerce platforms, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global gastrointestinal OTC drugs market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on drug class, indication, and end user.

Drug Class Insights:

Laxatives

Gastrointestinal Cancer Treatments

Gastric Acid Reducers

Anti-Diarrheal

Proton Pump Inhibitors

H2 Inhibitors

Gastric Acid Neutralizers

Bowel Anti-Inflammatory

Anti-Emetics

The report has provided a detailed breakup and analysis of the gastrointestinal OTC drugs market based on the drug class. This includes laxatives, gastrointestinal cancer treatments, gastric acid reducers, anti-diarrheal, proton pump inhibitors, H2 inhibitors, gastric acid neutralizers, bowel anti-inflammatory, and anti-emetics.

Indication Insights:

Gastroesophageal Reflux Disease (GERD) or Heartburn

Constipation

Diarrhea

Motion Sickness

Others

A detailed breakup and analysis of the gastrointestinal OTC drugs market based on the indication has also been provided in the report. This includes gastroesophageal reflux disease (GERD) or heartburn, constipation, diarrhea, motion sickness, and others.

End User Insights:

Hospitals

Clinics

Others

A detailed breakup and analysis of the gastrointestinal OTC drugs market based on the end user has also been provided in the report. This includes hospitals, clinics, and others.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for gastrointestinal OTC drugs. Some of the factors driving the North America gastrointestinal OTC drugs market included the rising prevalence of gastrointestinal disorders, increasing awareness among the masses, and various product innovations.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global gastrointestinal OTC drugs market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boehringer Ingelheim GmbH, Johnson & Johnson, Prestige Consumer Healthcare Inc., Purdue Pharma L.P, Sanofi, Zydus Lifesciences Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global gastrointestinal OTC drugs market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global gastrointestinal OTC drugs market?
  • What is the impact of each driver, restraint, and opportunity on the global gastrointestinal OTC drugs market?
  • What are the key regional markets?
  • Which countries represent the most attractive gastrointestinal OTC drugs market?
  • What is the breakup of the market based on the drug class?
  • Which is the most attractive drug class in the gastrointestinal OTC drugs market?
  • What is the breakup of the market based on the indication?
  • Which is the most attractive indication in the gastrointestinal OTC drugs market?
  • What is the breakup of the market based on end user?
  • Which is the most attractive end user in the gastrointestinal OTC drugs market?
  • What is the competitive structure of the global gastrointestinal OTC drugs market?
  • Who are the key players/companies in the global gastrointestinal OTC drugs market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Gastrointestinal OTC Drugs Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Drug Class

  • 6.1  Laxatives
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Gastrointestinal Cancer Treatments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Gastric Acid Reducers
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4  Anti-Diarrheal
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5  Proton Pump Inhibitors
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6  H2 Inhibitors
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7  Gastric Acid Neutralizers
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8  Bowel Anti-Inflammatory
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast
  • 6.9  Anti-Emetics
    • 6.9.1 Market Trends
    • 6.9.2 Market Forecast

7   Market Breakup by Indication

  • 7.1  Gastroesophageal Reflux Disease (GERD) or Heartburn
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Constipation
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Diarrhea
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4  Motion Sickness
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5  Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8   Market Breakup by End User

  • 8.1  Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9   Market Breakup by Region

  • 9.1  North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2  Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3  Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4  Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5  Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10  Drivers, Restraints, and Opportunities

  • 10.1  Overview
  • 10.2  Drivers
  • 10.3  Restraints
  • 10.4  Opportunities

11  Value Chain Analysis

12  Porters Five Forces Analysis

  • 12.1  Overview
  • 12.2  Bargaining Power of Buyers
  • 12.3  Bargaining Power of Suppliers
  • 12.4  Degree of Competition
  • 12.5  Threat of New Entrants
  • 12.6  Threat of Substitutes

13  Price Analysis

14  Competitive Landscape

  • 14.1  Market Structure
  • 14.2  Key Players
  • 14.3  Profiles of Key Players
    • 14.3.1  Boehringer Ingelheim GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2  Johnson & Johnson
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3  Prestige Consumer Healthcare Inc. 
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4  Purdue Pharma L.P
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5  Sanofi
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6  Zydus Lifesciences Limited
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Gastrointestinal OTC Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Gastrointestinal OTC Drugs Market: Breakup by Drug Class (in %), 2022
  • Figure 5: Global: Gastrointestinal OTC Drugs Market: Breakup by Indication (in %), 2022
  • Figure 6: Global: Gastrointestinal OTC Drugs Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Gastrointestinal OTC Drugs Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Gastrointestinal OTC Drugs (Laxatives) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Gastrointestinal OTC Drugs (Laxatives) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Gastrointestinal OTC Drugs (Gastrointestinal Cancer Treatments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Gastrointestinal OTC Drugs (Gastrointestinal Cancer Treatments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Gastrointestinal OTC Drugs (Gastric Acid Reducers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Gastrointestinal OTC Drugs (Gastric Acid Reducers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Gastrointestinal OTC Drugs (Anti-Diarrheal) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Gastrointestinal OTC Drugs (Anti-Diarrheal) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Gastrointestinal OTC Drugs (Proton Pump Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Gastrointestinal OTC Drugs (Proton Pump Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Gastrointestinal OTC Drugs (H2 Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Gastrointestinal OTC Drugs (H2 Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Gastrointestinal OTC Drugs (Gastric Acid Neutralizers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Gastrointestinal OTC Drugs (Gastric Acid Neutralizers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Gastrointestinal OTC Drugs (Bowel Anti-Inflammatory) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Gastrointestinal OTC Drugs (Bowel Anti-Inflammatory) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Gastrointestinal OTC Drugs (Gastroesophageal Reflux Disease (GERD) or Heartburn) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Gastrointestinal OTC Drugs (Gastroesophageal Reflux Disease (GERD) or Heartburn) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Gastrointestinal OTC Drugs (Constipation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Gastrointestinal OTC Drugs (Constipation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Gastrointestinal OTC Drugs (Diarrhea) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Gastrointestinal OTC Drugs (Diarrhea) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Gastrointestinal OTC Drugs (Motion Sickness) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Gastrointestinal OTC Drugs (Motion Sickness) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Gastrointestinal OTC Drugs (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Gastrointestinal OTC Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Gastrointestinal OTC Drugs (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Gastrointestinal OTC Drugs (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Gastrointestinal OTC Drugs (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Gastrointestinal OTC Drugs (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Gastrointestinal OTC Drugs (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Gastrointestinal OTC Drugs (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: North America: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: North America: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: United States: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: United States: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Canada: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Canada: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Asia-Pacific: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Asia-Pacific: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: China: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: China: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Japan: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Japan: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: India: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: India: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: South Korea: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: South Korea: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Australia: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Australia: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Indonesia: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Indonesia: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Others: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Others: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Europe: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Europe: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Germany: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Germany: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: France: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: France: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: United Kingdom: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: United Kingdom: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Italy: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Italy: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Spain: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Spain: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Russia: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Russia: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Latin America: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Latin America: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Brazil: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Brazil: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Mexico: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Mexico: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Others: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Others: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Middle East and Africa: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Middle East and Africa: Gastrointestinal OTC Drugs Market: Breakup by Country (in %), 2022
  • Figure 88: Middle East and Africa: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Global: Gastrointestinal OTC Drugs Industry: Drivers, Restraints, and Opportunities
  • Figure 90: Global: Gastrointestinal OTC Drugs Industry: Value Chain Analysis
  • Figure 91: Global: Gastrointestinal OTC Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Gastrointestinal OTC Drugs Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
  • Table 3: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 4: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Gastrointestinal OTC Drugs Market: Competitive Structure
  • Table 7: Global: Gastrointestinal OTC Drugs Market: Key Players